S. Blum

发表

The clinical profile of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2020, Journal of Neurology.

Use and monitoring of low dose rituximab in myasthenia gravis

P. Mccombe, R. Henderson, P. Pillans, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Anti-glutamic acid decarboxylase antibody screening in first-episode psychosis

D. Gillis, D. Siskind, C. O'Gorman, 2022, The Australian and New Zealand journal of psychiatry.

Immunoglobulin-responsive refractory epilepsy – 3 cases with a similar EEG pattern

A. Lehn, S. Dionisio, S. Blum, 2013, Seizure.

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

S. Broadley, J. Lechner-Scott, M. Slee, 2020, Frontiers in Neurology.

Psychiatric manifestations of autoimmune encephalitis.

H. Butzkueven, D. Velakoulis, J. Kulkarni, 2022, Autoimmunity reviews.

Voltage-gated potassium channel blanket testing in first-episode psychosis: Diagnostic nihilism?

D. Gillis, C. O'Gorman, S. Blum, 2021, The Australian and New Zealand journal of psychiatry.

Atypical clinical presentations of the A3243G mutation, usually associated with MELAS

P. Mccombe, R. Henderson, R. D. Henderson, 2011, Internal medicine journal.

The tibialis anterior response revisited

A. Lehn, R. Henderson, S. Dionisio, 2014, Journal of Neurology.

Susac syndrome and multifocal motor neuropathy first manifesting in pregnancy

Z. Ioannides, P. Mccombe, R. Henderson, 2013, The Australian & New Zealand journal of obstetrics & gynaecology.

Clinical features and impact of myasthenia gravis disease in Australian patients

P. Mccombe, D. Gillis, S. Blum, 2015, Journal of Clinical Neuroscience.

Clinical features of patients with Guillain‐Barré syndrome at seven hospitals on the East Coast of Australia

P. Mccombe, J. Spies, S. Blum, 2013, Journal of the peripheral nervous system : JPNS.

Guillain-Barré Syndrome: Modern Theories of Etiology

P. Mccombe, S. Blum, S. Reddel, 2011, Current allergy and asthma reports.

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome

P. Mccombe, J. Spies, S. Blum, 2014, Journal of Neuroimmunology.

Cognitive function and oral health in relapsing–remitting multiple sclerosis

J. Henry, S. Blum, M. Nangle, 2021, Clinical Oral Investigations.

A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma

C. O'Gorman, S. Blum, K. Horwood, 2021, Journal of Neuroimmunology.

058 ANTI-CASPR2-ANTIBODY associated encephalitis in a 63-year old male with chronic lymphocytic leukaemia

A. Lehn, D. Gillis, C. O'Gorman, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

S. Vucic, J. Parratt, C. Shaw, 2022, BMJ Neurology Open.

A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction

Victoria E. Jackson, M. Brown, J. Reveille, 2020, Nature Communications.

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders

K. Prain, S. Blum, R. Wong, 2014, Neurology.

Screening for anti-NMDAR encephalitis in psychiatry.

D. Siskind, S. Kisely, C. O'Gorman, 2020, Journal of psychiatric research.

Phenotypic variability within the desminopathies: A case series of three patients

P. Mccombe, R. Henderson, R. Denman, 2023, Frontiers in Neurology.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

S0033291719003283jra 435..440

D. Siskind, C. O'Gorman, S. Blum, 2021 .

Psychiatric management of anti-NMDAR encephalitis: a cohort analysis

D. Siskind, C. O'Gorman, S. Blum, 2019, Psychological Medicine.

Atypical N-methyl-D-aspartate receptor encephalitis and a hippocampal tumour

S. Blum, T. Theodoros, N. Warren, 2017, The Australian and New Zealand journal of psychiatry.

Genetics of Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions

P. Mccombe, S. Blum, 2014, Journal of the peripheral nervous system : JPNS.

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis

P. Mccombe, S. Blum, P. Csurhes, 2015, Journal of Neuroimmunology.

Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review

G. Robinson, D. Gillis, C. Finke, 2018, Journal of clinical and experimental neuropsychology.

Cognitive and Social Functioning Deficits after Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Exploratory Case Series

D. Spooner, G. Robinson, D. Gillis, 2016, Journal of the International Neuropsychological Society.

Different types of cerebellar hypometria associated with a distinct topography of the lesion in cerebellum

E. Godaux, M. Manto, F. Setta, 1998, Journal of the Neurological Sciences.

Missense mutations in the MLKL ‘brace’ region lead to lethal neonatal inflammation in mice and are present in high frequency in humans

M. Brown, J. Reveille, A. Bassuk, 2019, bioRxiv.

A Case Series of Patients With Autoimmune Myasthenia Gravis in Association With Invasive Thymoma

P. Mccombe, R. Henderson, S. Blum, 2016, Journal of clinical neuromuscular disease.

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

A. Coulthard, M. Pender, Z. Ioannides, 2021, Frontiers in Neurology.

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

084 Treating yourself: a glucocorticoid secreting tumour suppressing myasthenia gravis

D. Gillis, K. Prain, S. Blum, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis

S. Broadley, J. Lechner-Scott, M. Slee, 2021, Frontiers in Neurology.

Analysing triggers for anti‐NMDA‐receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: results from the Queensland Autoimmune Encephalitis cohort

D. Gillis, K. Prain, S. Blum, 2021, Internal medicine journal.

Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab

P. Mccombe, R. Henderson, D. Gillis, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Overview of new developments in mysthenia gravis therapy

S. Blum, R. Beer, 2020 .

Antiglycine receptor antibody related disease: a case series and literature review

S. Broadley, A. Vincent, S. Irani, 2018, European Journal of Neurology.

An Australian State-Based Cohort Study of Autoimmune Encephalitis Cases Detailing Clinical Presentation, Investigation Results, and Response to Therapy

S. Broadley, P. Mccombe, C. Muller, 2021, Frontiers in Neurology.

Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias.

Jeremy R. B. Newman, P. Silburn, G. Sutherland, 2012, Parkinsonism & related disorders.

Incidence and prevalence of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

059 Teratoma with glycine, NMDA & VGKC antibodies presenting with severe weakness, respiratory failure & corticospinal tract dysfunction

D. Gillis, C. O'Gorman, K. Prain, 2018, Journal of Neurology Neurosurgery & Psychiatry.

J. Henry, S. Blum, M. Nangle, 2022, Journal of oral rehabilitation.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

Episodic foresight in multiple sclerosis.

J. Henry, P. Rendell, S. Blum, 2021, Neuropsychology.

Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis

S. Broadley, T. Wijeratne, H. Butzkueven, 2022, Neurological Sciences.

Genome-wide association study in Guillain-Barré syndrome

M. Brown, Zhixiu Li, Ying Ji, 2018, Journal of Neuroimmunology.

The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis

S. Patterson, D. Gillis, K. Prain, 2018, BJPsych Open.

A case of Anti-LGi1 antibody positive autoimmune epilepsy following deep brain stimulator implantation for essential tremor

A. Lehn, S. Blum, R. Beer, 2021, Journal of Neuroimmunology.

Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis

D. Gillis, S. Blum, James G Scott, 2018, The Australian and New Zealand journal of psychiatry.

Serum and CSF Anti-NMDAR Antibody Testing in Psychiatry.

D. Siskind, D. Gillis, C. O'Gorman, 2019, The Journal of neuropsychiatry and clinical neurosciences.

Evaluation of the proposed anti‐N‐methyl‐d‐aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients

D. Siskind, S. Kisely, C. O'Gorman, 2020, Acta psychiatrica Scandinavica.

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders

K. Prain, S. Blum, R. Wong, 2014, Neurology.

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

S. Broadley, A. Kermode, D. Wakefield, 2019, Acta Neuropathologica Communications.

A case of immune-mediated encephalitis related to daclizumab therapy

M. Devlin, C. O'Gorman, S. Blum, 2018, Multiple sclerosis.

Managing the generalised tonic–clonic seizure and preventing progress to status epilepticus: a stepwise approach

R. Boyle, S. Blum, S. Dionisio, 2013, Internal medicine journal.